News Square
Global Crypto News · Real-time Aggregation
📚 Deep Analysis
More →GRVT Burns 1.1 Million Tokens as Countdown to Grvt 2.0 Begins
<strong>[PRESS RELEASE – Singapore, Singapore, October 20th, 2026]</strong> <strong>The discretionary buyback represents close to 1% of circulating supply and precedes four planned product milestones culminating in Grvt 2.0.</strong> <a href="https://grvt.io/" rel="nofollow noopener" target="_blank">>Grvt</a>, a self-custodial trading platform built on its own zero-knowledge (ZK) chain, announced that the Foundation’s token issuer has completed its first GRVT token buyback, purchasing and burning 1.1 million GRVT tokens on the open market. The transaction permanently removed close to 1% of GRVT’s circulating supply at the time of purchase. It marks the first of five milestones ahead of the planned launch of Grvt 2.0 at the end of November 2026. <strong>A Discretionary Buyback with On-Chain Verification</strong> The Foundation’s token issuer intends to conduct further buybacks on a monthly basis. Each transaction remains entirely at the issuer’s discretion, with no predetermined purchase amount or guaranteed schedule. Buybacks are executed through an independent execution partner, with purchased tokens transferred to a designated burn address and permanently removed from circulation. The transactions can be independently verified through the <a href="https://grvt.io/exchange/buybacks" rel="nofollow noopener" target="_blank">>public buyback dashboard</a>, which records the number of tokens purchased and burned, the percentage of circulating supply represented, cumulative burns and on-chain transaction hashes. “The GRVT token is an important part of the ecosystem we are building,” said <strong>Hong, co-founder and CEO of Grvt</strong>. “We welcome the issuer’s buybacks as a demonstration of its long-term commitment to the ecosystem and community. Grvt is expanding its products and markets, and the issuer’s buybacks sit alongside that as a supportive mechanism aimed at reducing circulating token supply.” <strong>Grvt Outlines Four Product Milestones</strong> The announcement follows GRVT’s token generation event in July 2026 and precedes a series of planned launches. <strong>Grvt Earn, scheduled for the End of October,</strong> will introduce yield opportunities backed by tokenized assets, with target yields of up to 11%. Potential returns are expected to derive from underlying asset cash flows, including interest, premiums and invoice-related income. Asset-supplying partners will be announced at launch. Target yields are not guaranteed. <strong>Stable Funding Perps, scheduled for November,</strong> will introduce perpetual futures linked to commodities, stocks, foreign exchange and indices. The contracts are planned to carry zero trading fees and use once-daily funding. Grvt aims to list more than 1,000 markets by the end of December 2026. <strong>Yield as Margin, also scheduled for November,</strong> will allow eligible Grvt Earn balances to support trading positions while continuing to accrue yield, subject to applicable product terms
OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
OpenAI has bought Orchestra Bio, a San Francisco startup whose AI agents help drug companies keep sprawling development programs on schedule, the ChatGPT maker <a href="https://openai.com/index/openai-to-acquire-orchestra-bio/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>announced Tuesday</a>. “Our goal is to help scientists make discoveries and manage the work needed to turn them into treatments that reach patients sooner,” OpenAI said in the announcement. Orchestra’s team and platform will be folded into <a href="https://openai.com/rosalind/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>Rosalind</a>, OpenAI’s family of AI models and tools for biologists and chemists. The financial terms were not disclosed. Getting a new medicine from first idea to U.S. approval takes time—up to 15 years according to OpenAI. Every month shaved off that timeline is a month earlier that a new treatment can reach the people waiting for it, and a month earlier that the company can generate cash. The process is also absurdly expensive: bringing one approved drug to market can cost more than <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12668846/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>$2.6 billion</a>, and <a href="https://arxiv.org/pdf/2106.05386" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">fewer than 10%</a> of candidates that enter human testing ever make it to pharmacy shelves. Beyond the science itself, OpenAI says drug teams have to coordinate work across internal departments and outside partners, often relying on systems that don’t talk to each other. Those partners usually include contract research organizations, the outside labs hired to run studies, and contract manufacturers that produce the experimental drug. Orchestra’s AI agents—software that can watch over tasks and flag problems on its own—work out which activities and deadlines take the hit, gather the relevant information and compare ways to respond, while scientists and program leaders make the final call. Founded in the fall of 2022, Orchestra raised its <a href="https://jobs.8vc.com/companies/orchestra/jobs/28818089-senior-software-engineer" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>seed round</a> from Andreessen Horowitz, Definition Capital, Insight Partners, and 8VC, and about $20 million in total, according to <a href="https://www.caplight.com/company/orchestra-bio" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">Caplight data</a>. The company should not be confused with Orchestra BioMed, an unrelated Nasdaq-listed medical device maker that trades under the ticker OBIO. In April, OpenAI launched <a href="https://decrypt.co/364783/openai-gpt-rosalind-drug-discovery-life-sciences-model" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">GPT-Rosalind</a>, a model built specifically for biology and dru
Google, Temasek, and Bain report: AI will drive 17% growth in Southeast Asia's digital economy.
According to a report released by Google, Temasek Holdings, and Bain & Company, AI will drive about 17% growth in Southeast Asia's digital economy, with the total scale expected to reach $368 billion.
SlowMist discloses two critical RCE vulnerabilities and recommends that crypto platforms upgrade.
CoinWorld data: SlowMist Chief Information Security Officer 23pds posted that PHP has disclosed two critical remote code execution (RCE) vulnerabilities, numbered CVE-2026-109618 and CVE-2026-109619, both with a CVSS v4.0 score of 9.2. Technical details, exploitation conditions, and affected versions have not yet been officially confirmed. The official security update is expected to be released on October 21, 2026, at 14:00 UTC (22:00 Beijing time). SlowMist's asset scan targeting PHP usage in the crypto industry indicates risks, and it recommends that all platforms, DeFi projects, and wallets upgrade and audit.
Morgan Stanley: Refined oil product markets may remain supply-tight until 2027.
According to CoinWorld news, Morgan Stanley stated that even if current war-related disruptions ease, the refined products market may remain in a tight supply state until mid-2027, because "an unusually large scale of refinery maintenance activity" is constraining global supply.
SlowMist: Network-wide asset scan statistics targeting PHP usage in the crypto industry
According to a CoinWorld report, SlowMist MistEye has conducted a network-wide asset scan and statistics targeting PHP usage in the cryptocurrency industry, reminding major platforms, DeFi projects, wallets, and other parties to be aware of the risks and to carry out upgrades.
BTC large holder account long-short ratio is 1.5833
BiJie Network data: The latest 4-hour snapshot for BTCUSDT shows that among the top 20% of accounts by margin balance, the long-short account ratio is 1.5833, with more net long accounts among large holders. Compared with the same-metric snapshot 24 hours ago, it is down 0.1852; compared with the same-metric snapshot 7 days ago, it is up 0.2348.
Binance will list 5 bstocks tokenized stocks today at 20:00.
CoinWorld news: Binance will list 5 bstocks tokenized stocks today at 20:00, including robostrategy (botb), Berkshire Hathaway (brkbb), KraneShares STAR 50 ETF (kstrb), Direxion Daily 20-Year Treasury Bull 3X ETF (tmfb), and Vistra (vstb), all as USDT spot trading pairs. Spot strategy trading bots will also be enabled at the same time, and the rebalancing bot will be available within 24 hours after listing. Within 1 hour after bstocks go live, they will be integrated into Binance Convert with zero conversion fees. From listing until 07:59 (UTC+8) on November 1, maker fees will be waived.
The principal culprit in the Blue Sky Gerui massive illegal deposit-taking case has handed over £5.6 million to the British government.
According to a report by the Daily Mail, hok seng ling, the behind-the-scenes "steward" of Qian Zhimin, the principal culprit in the massive illegal absorption of public deposits case involving Blue Sky Gerui, has fully paid 5.6 million pounds to the British government (approximately 5,603,305 pounds in confiscation order assets plus interest), most of which consisted of crypto assets seized when he was arrested. The Malaysian national was previously sentenced to 4 years and 11 months in prison for money laundering. At the same time, the London High Court is engaged in an intense legal battle over the final disposition rights of 61,000 bitcoins seized by British police. Lawyers representing nearly 130,000 victim investors oppose the UK Treasury retaining the appreciation gains from the bitcoins. The judge ruled that Chinese law applies to the claim case and required the victims to prove that they hold legal ownership of the bitcoins in question under the current Chinese legal framework, which increases the difficulty of the claim. If they cannot prove it, a large portion of this huge appreciated asset may legally belong to the British government.
AWS data centers face power supply bottlenecks, and AI computing systems cannot be activated.
According to CoinWorld news, some data centers under Amazon Web Services (AWS) are facing power supply capacity bottlenecks, preventing rack-level AI computing systems that have been ordered from being put into use on schedule. AWS expects to receive racks worth about $3 billion per month starting in August this year, but some equipment can only be temporarily stored in makeshift warehouses due to insufficient power supply. AWS is closely monitoring the power supply progress of its data centers and is using a combination of measures to accelerate power readiness. In addition, AWS has adjusted its "cash on delivery" practice by taking ownership of racks at an earlier stage of the supply chain to ensure the supply of computing resources, but this also means it must bear the losses caused by delays in putting racks into operation.